MOXIFLOXACIN KABI

Solution for infusion, 400mg/250ml
RxActive license

Active substance (INN)

moxifloxacin

Pharmaceutical form

Pharmaceutical formSolution for infusion
Strength400mg/250ml
PackagingUkupno 10 boca plastičnih sa po 250ml rastvora za infuziju u kartonskoj kutiji
ManufacturerFresenius Kabi Polska Sp. z o.o., Poland
Therapeutic groupAnti-infectives for systemic use (J01MA14)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateFebruary 23, 2026

Analogs in Montenegro

6

Other medicines with the same active substance

Source: CInMED register